STAT+: Unsealed court documents reveal a whistleblower suit over UnitedHealth use of an artery disease test
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
A law firm representing health care fraud whistleblowers is suing UnitedHealth Group over its use of a peripheral artery disease test, called QuantaFlo, to increase payments it received from the government Medicare program, after the Department of Justice declined to pursue a case against the nation\u2019s largest health care company.\u00a0<\/p>\n
The DOJ\u2019s decision was revealed in federal court documents unsealed on Friday as the government disclosed a $29.75 million settlement of fraud claims with Semler Scientific, the maker of the QuantaFlo test. The Justice Department also reached a $7.2 million agreement with CR Bard, the former distributor of the test now owned by BD, according to the documents unsealed in the Middle District Court of Florida.<\/p>\n
\u201cMedical device companies that misrepresent the capabilities of their products and encourage providers to bill Medicare for services that do not meet coverage requirements drain critical taxpayer-funded resources,\u201d said Isaac Bledsoe, acting special agent in charge of the Health and Human Services Department Office of Inspector General, in a statement<\/a>.\u00a0<\/p>\n Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n